| Trial ID: | L3085 |
| Source ID: | NCT00569465
|
| Associated Drug: |
Arginine
|
| Title: |
N-Acetylcysteine and Arginine Administration in Diabetic Patients
|
| Acronym: |
NACARGPAO
|
| Status: |
TERMINATED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus|Hypertension
|
| Interventions: |
DRUG: Arginine|DRUG: Acetylcysteine|DRUG: Placebo
|
| Outcome Measures: |
Primary: arterial blood pressure decrease, 6 months | Secondary: oxidative parameters decrease, 6 months
|
| Sponsor/Collaborators: |
Sponsor: University of Turin, Italy
|
| Gender: |
MALE
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
24
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2005-01
|
| Completion Date: |
2006-01
|
| Results First Posted: |
|
| Last Update Posted: |
2007-12-07
|
| Locations: |
"San Giovanni Battista" Hospital of Turin, Turin, 10126, Italy
|
| URL: |
https://clinicaltrials.gov/show/NCT00569465
|
